Clinical Trial Update: Reduction of Bacteria in MRSA Positive Ulcers [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 trial sponsored by Nitric BioTherapeutics evaluated the reduction of bacteria in MRSA-positive leg ulcers and pressure ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leg Ulcer
• Pressure Ulcer

Snippet

Sponsor: Nitric BioTherapeutics, Inc | Conditions: Leg Ulcer, Pressure Ulcer | Phase 1, Phase 2 | Status: TERMINATED